The following is a summary of “COVID-19 Treatments: Then and Now,” published in the November 2023 issue of Allergy and Clinical Immunology by Mustafa et al.
The coronavirus disease 2019 (COVID-19) outbreak has undergone several changes over the previous three or more years. These changes have also occurred in the methods that individuals attempt to prevent being ill and treat diseases. Broad non-drug therapies, such as mask legislation and government restrictions that encourage people to keep away from individuals who are sick, have been replaced with more tailored efforts to minimize risk as COVID-19 transitions from a pandemic to a chronic disease.
This is because drug-based treatments are more effective in reducing the risk of infection. In the event that viral strains developed resistance, monoclonal antibody treatments, which were used for the treatment and prevention of sickness, ceased to be effective. Oral antiviral medications are now the most popular therapy method for those not in the hospital.
On the other hand, systemic corticosteroids continue to be the most essential component of treatment for individuals who need more assistance in breathing. Additionally, the use of additional medications that alter the immune system in some individuals who have been treated is supported by recent studies. It is essential to consider the fact that the COVID-19 epidemic brought to light both novel and ground-breaking medical research and development, in addition to serious issues with the way the world responded to the outbreak. This research provides a current and comprehensive look at how to prevent and treat COVID-19.
Source: sciencedirect.com/science/article/abs/pii/S221321982300819X
